He Yun, Cui Jiejie, He Tongchuan, Bi Yang
Department of Pediatric Surgery, The Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China.
Stem Cell Biology and Therapy Laboratory, The Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China.
Mol Med Rep. 2015 Aug;12(2):2872-8. doi: 10.3892/mmr.2015.3772. Epub 2015 May 12.
5-azacytidine (5-azaC) is known to induce cardiomyocyte differentiation. However, its function in hepatocyte differentiation is unclear. The present study investigated the in vitro capability of 5-azaC to promote maturation and differentiation of mouse embryonic hepatic progenitor cells, with the aim of developing an approach for improving hepatic differentiation. Mouse embryonic hepatic progenitor cells (HP14.5 cells) were treated with 5-azaC at concentrations from 0 to 20 μmol/l, in addition to hepatocyte induction culture medium. Hepatocyte induction medium induces HP14.5 cell differentiation. 5-azaC may enhance the albumin promotor-driven Gaussia luciferase (ALB-GLuc) activity in induced HP14.5 cells. In the present study 2 μmol/l was found to be the optimum concentration with which to achieve this. The expression of hepatocyte-associated factors was not significantly different between the group treated with 5-azaC alone and the control group. The mRNA levels of ALB; cytokeratin 18 (CK18); tyrosine aminotransferase (TAT); and cytochrome p450, family 1, member A1 (CYP1A1); in addition to the protein levels of ALB, CK18 and uridine diphosphate glucuronyltransferase 1A (UGT1A) in the induced group with 5-azaC, were higher than those in the induced group without 5-azaC, although no significant differences were detected in expression of the hepatic stem cell markers, DLK and α-fetoprotein, between the two groups. Treatment with 5-azaC alone did not affect glycogen synthesis or indocyanine green (ICG) metabolic function in HP14.5 cells, although it significantly increased ICG uptake and periodic acid-Schiff-positive cell numbers amongst HP14.5 cells. Therefore, the present study demonstrated that treatment with 5-azaC alone exerted no effects on the maturation and differentiation of HP14.5 cells. However, 5-azaC exhibited a synergistic effect on the terminal differentiation of induced hepatic progenitor cells in association with a hepatic induction medium.
已知5-氮杂胞苷(5-azaC)可诱导心肌细胞分化。然而,其在肝细胞分化中的作用尚不清楚。本研究调查了5-azaC在体外促进小鼠胚胎肝祖细胞成熟和分化的能力,旨在开发一种改善肝脏分化的方法。除肝细胞诱导培养基外,将小鼠胚胎肝祖细胞(HP14.5细胞)用浓度为0至20μmol/l的5-azaC处理。肝细胞诱导培养基可诱导HP14.5细胞分化。5-azaC可能增强诱导的HP14.5细胞中白蛋白启动子驱动的海肾荧光素酶(ALB-GLuc)活性。在本研究中,发现2μmol/l是实现此目的的最佳浓度。单独用5-azaC处理的组与对照组之间肝细胞相关因子的表达无显著差异。在5-azaC诱导组中,白蛋白(ALB)、细胞角蛋白18(CK18)、酪氨酸转氨酶(TAT)和细胞色素P450家族1成员A1(CYP1A1)的mRNA水平,以及ALB、CK18和尿苷二磷酸葡萄糖醛酸转移酶1A(UGT1A)的蛋白水平,均高于无5-azaC的诱导组,尽管两组之间肝干细胞标志物DLK和甲胎蛋白的表达未检测到显著差异。单独用5-azaC处理对HP14.5细胞中的糖原合成或吲哚菁绿(ICG)代谢功能无影响,尽管它显著增加了HP14.5细胞中的ICG摄取和过碘酸-希夫阳性细胞数量。因此,本研究表明单独用5-azaC处理对HP14.5细胞的成熟和分化无影响。然而,5-azaC与肝脏诱导培养基联合对诱导的肝祖细胞的终末分化表现出协同作用。